- Home
- ONCO
ONCO
Onconetix Inc.
as 11-15-2024 4:00pm EST
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 24.1M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 71.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -104.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.27 - $21.40 | Next Earning Date: | 11-26-2024 |
| Revenue: | $1,463,746 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Onconetix Inc. News
ONCO Breaking Stock News: Dive into ONCO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
GlobeNewswire
a month ago
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
GlobeNewswire
2 months ago
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
GlobeNewswire
4 months ago
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
GlobeNewswire
4 months ago
Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
GlobeNewswire
9 months ago
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
PR Newswire
10 months ago
CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS
GlobeNewswire
10 months ago
Jet.AI to Participate in A.G.P.’s Virtual Technology Conference
Compare ONCO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONCO Onconetix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.